Table 2.
Clinical characteristics of recurrent VH and treatments.
| Patients | Number of rebleeding episodes | Number of IVIR for RVH | No. of S.PRP | TRT of RVH (weeks) | Surgical intervention (V/AVI) |
|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 13 | No |
| 2 | 1 | 2 | 1 | 8 | No |
| 3 | 1 | 2 | 1 | 7 | No |
| 4 | 2 | 5 | 2 | 15 | No |
| 5 | 1 | 1 | 0 | 5 | No |
| 6 | 1 | 2 | 1 | 7 | No |
| 7∗ | 2 | 5 | / | 29 | V |
| 8∗ | 3 | 6 | / | 38 | V |
| 9 | 1 | 1 | 0 | 2 | No |
| 10∗ | 2 | 4 | / | 21 | V/V |
| 11 | 1 | 1 | 1 | 3 | No |
| 12∗ | 2 | 6 | / | 29 | V |
| 13 | 2 | 4 | 1 | 15 | No |
| 14∗ | 1 | 5 | / | 11 | V |
| 15∗ | 3 | 5 | / | 17 | V |
| 16 | 3 | 6 | 1 | 21 | No |
| 17∗ | 1 | 4 | / | 36 | V/V/AVI |
| 18∗ | 2 | 5 | / | 44 | V/V + AVI |
No. of S.PRP = number of supplementary PRP in patients without surgical intervention; IVIR = intravitreal injection of ranibizumab; RVH = recurrent vitreous hemorrhage; TRT = total reabsorption time; V = vitrectomy; AVI = Ahmed valve implantation; V/V = two vitrectomies at different time; ∗ represents patients having surgical intervention.